Literature DB >> 31900644

Multimodal imaging characterization of peripheral drusen.

Eleonora Corbelli1, Enrico Borrelli1, Mariacristina Parravano2, Riccardo Sacconi1, Marta Gilardi2, Eliana Costanzo2, Michele Cavalleri1, Lea Querques1, Francesco Bandello1, Giuseppe Querques3.   

Abstract

PURPOSE: To provide an integrate multimodal imaging characterization of peripheral drusen in the eyes with and without macular signs of age-related macular degeneration (AMD) and to analyze their association with macular findings.
METHODS: In this retrospective, cross-sectional study, subjects with peripheral drusen were imaged with the Optos (Optos PLC, Dunfermline, Scotland, UK) and Spectralis devices to obtain referenced spectral domain optical coherence tomography (SD-OCT) images. Two experienced graders independently graded the ultra-widefield (UWF) pseudocolor and fundus autofluorescence (FAF) images for the presence of peripheral drusen and analyzed peripheral druse features using OCT. Main outcome measures included quantitative and qualitative assessment of peripheral drusen.
RESULTS: Fifty-seven eyes (30 subjects) were included in the analysis. Mean ± SD age was 77.6 ± 9.2 years (range 54-97 years). On pseudocolor images, graders identified the presence of drusen in all the enrolled eyes (Cohen's kappa was 1.0). On FAF images, Cohen's kappa was 0.71. In the topographical assessment, peripheral drusen were detected in 23 cases in the temporal region, in 40 cases in the nasal region, in 40 cases in the inferior region, and in 42 cases in the superior region. On SD-OCT images, peripheral drusen had a high reflective core in 97.1% of cases, while remaining drusen were characterized by a low reflective core. The macula was affected by early/intermediate AMD in 23 eyes (43.5%) and late AMD in 6 eyes (10.5%).
CONCLUSIONS: We provided an integrate multimodal imaging assessment of peripheral drusen in the eyes with and without AMD. Peripheral drusen were characterized by distinguished features that may suggest that these lesions constitute a distinct disease, rather than representing an expansion of AMD.

Entities:  

Keywords:  Age-related macular degeneration; Drusen; Multimodal imaging; Peripheral retina; Ultra-widefield

Year:  2020        PMID: 31900644     DOI: 10.1007/s00417-019-04586-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  Drusen characterization with multimodal imaging.

Authors:  Richard F Spaide; Christine A Curcio
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

2.  Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane.

Authors:  D Pauleikhoff; S Zuels; G S Sheraidah; J Marshall; A Wessing; A C Bird
Journal:  Ophthalmology       Date:  1992-10       Impact factor: 12.079

3.  Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.

Authors:  Amitha Domalpally; Traci E Clemons; Ronald P Danis; SriniVas R Sadda; Catherine A Cukras; Cynthia A Toth; Thomas R Friberg; Emily Y Chew
Journal:  Ophthalmology       Date:  2017-01-12       Impact factor: 12.079

4.  A Population-Based Ultra-Widefield Digital Image Grading Study for Age-Related Macular Degeneration-Like Lesions at the Peripheral Retina.

Authors:  Imre Lengyel; Adrienne Csutak; Daniela Florea; Irene Leung; Alan C Bird; Fridbert Jonasson; Tunde Peto
Journal:  Ophthalmology       Date:  2015-04-11       Impact factor: 12.079

5.  Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy.

Authors:  Christine A Curcio; J Brett Presley; Goldis Malek; Nancy E Medeiros; Dina V Avery; Howard S Kruth
Journal:  Exp Eye Res       Date:  2005-07-11       Impact factor: 3.467

6.  Wide-field fundus autofluorescence abnormalities and visual function in patients with cone and cone-rod dystrophies.

Authors:  Maho Oishi; Akio Oishi; Ken Ogino; Yukiko Makiyama; Norimoto Gotoh; Masafumi Kurimoto; Nagahisa Yoshimura
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

7.  Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.

Authors:  Malini Veerappan; Abdul-Karim M El-Hage-Sleiman; Vincent Tai; Stephanie J Chiu; Katrina P Winter; Sandra S Stinnett; Thomas S Hwang; G Baker Hubbard; Michelle Michelson; Randall Gunther; Wai T Wong; Emily Y Chew; Cynthia A Toth
Journal:  Ophthalmology       Date:  2016-10-25       Impact factor: 12.079

8.  Accumulation of cholesterol with age in human Bruch's membrane.

Authors:  C A Curcio; C L Millican; T Bailey; H S Kruth
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-01       Impact factor: 4.799

Review 9.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

10.  Clinical classification of age-related macular degeneration.

Authors:  Frederick L Ferris; C P Wilkinson; Alan Bird; Usha Chakravarthy; Emily Chew; Karl Csaky; SriniVas R Sadda
Journal:  Ophthalmology       Date:  2013-01-16       Impact factor: 12.079

View more
  2 in total

1.  Retinal phenotyping of variants of Alzheimer's disease using ultra-widefield retinal images.

Authors:  Lajos Csincsik; Nicola Quinn; Keir X X Yong; Sebastian J Crutch; Tunde Peto; Imre Lengyel
Journal:  Alzheimers Dement (Amst)       Date:  2021-08-20

Review 2.  Ultra-wide field retinal imaging: A wider clinical perspective.

Authors:  Vinod Kumar; Abhidnya Surve; Devesh Kumawat; Brijesh Takkar; Shorya Azad; Rohan Chawla; Daraius Shroff; Atul Arora; Ramandeep Singh; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.